A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen
Authors:
- Minji JoMJMinji Jo
- Drue L. WebbDWDrue L. Webb
- Shinako TakimotoSTShinako Takimoto
- Steven L. GoniasSGSteven L. Gonias
- 1 September 2012
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 24 (9) , 1847-1855
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cellsProceedings of the National Academy of Sciences, 2011
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its ReceptorJournal of Biological Chemistry, 2010
- Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathwaysSteroids, 2009
- uPAR promotes formation of the p130Cas–Crk complex to activate Rac through DOCK180Journal of Cell Biology, 2008
- Monomer–dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assembliesJournal of Cell Biology, 2007
- uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cellsJournal of Cell Biology, 2007
- uPAR-induced cell adhesion and migration: vitronectin provides the keyJournal of Cell Biology, 2007
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesProceedings of the National Academy of Sciences, 2006